EMA — authorised 22 August 2014
- Marketing authorisation holder: GE Healthcare AS
- Status: approved
EMA authorised Vizamyl on 22 August 2014
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 22 August 2014.
GE Healthcare AS holds the EU marketing authorisation.